bioLytical Laboratories launches INSTI® HCV Antibody Test in Australia, approved by ARTG.

bioLytical Laboratories Inc. has launched its INSTI® HCV Antibody Test in the Australian market, now included in the Australian Register of Therapeutic Goods (ARTG). The portable test aids in diagnosing Hepatitis C virus antibodies and demonstrated high accuracy in clinical studies. The company's Quality Management system is MDSAP/ISO 13485:2016 certified.